1. Home
  2. HUDI vs XLO Comparison

HUDI vs XLO Comparison

Compare HUDI & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

HOLD

Current Price

$1.32

Market Cap

17.3M

Sector

Industrials

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.68

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
XLO
Founded
1998
2016
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
41.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HUDI
XLO
Price
$1.32
$0.68
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
11.7K
522.5K
Earning Date
01-29-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,566,370.00
$31,804,000.00
Revenue This Year
N/A
$589.60
Revenue Next Year
N/A
$38.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
588.40
52 Week Low
$1.06
$0.62
52 Week High
$5.46
$1.70

Technical Indicators

Market Signals
Indicator
HUDI
XLO
Relative Strength Index (RSI) 48.79 35.82
Support Level $1.24 $0.68
Resistance Level $1.31 $0.73
Average True Range (ATR) 0.07 0.03
MACD 0.01 -0.00
Stochastic Oscillator 48.15 2.13

Price Performance

Historical Comparison
HUDI
XLO

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: